Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | NEPA to prevent chemotherapy-induced nausea and vomiting

Matti Aapro • 28 Sep 2019
ESMO 2019
General

Matti Aapro, MD, of Genolier Cancer Center, Genolier, Switzerland, outlines the efficacy of intravenous NEPA for the prevention of CINV following cisplatin and AC chemotherapy and whether is it a viable prevention treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Matti Aapro

3:39
Supportive care in cancer: more is needed
Matti Aapro • 28 Sep 2019
3:14
How to manage elderly patients on immunotherapy
Matti Aapro • 18 Jan 2019
2:47
Guidelines for adherence to CINV treatment
Matti Aapro • 4 Jan 2019
1:49
Minimising potentially futile treatments in advanced cancers
Matti Aapro • 4 Jan 2019

Related Videos

1:33
TranStar101: osemitamab, a novel CLDN18.2 inhibitor, in solid tumors
Yelena Janjigian • 8 Apr 2024
1:33
How can we enhance the efficacy of theranostic nanoparticles?
Debjani Pal • 8 Apr 2024
0:36
The benefits of SJPedPanel, a novel pediatric pan-cancer gene panel
Pandurang Kolekar • 8 Apr 2024
1:08
SJPedPanel: a pan-cancer gene panel for childhood cancers
Pandurang Kolekar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals